BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

5359

543328

KRSNAA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KRSNAA DIAGNOSTICS LTD performance

Today’s low

Today’s high

₹ 727.25 ₹ 755.45
₹ 731.75

52 week low

52 week high

₹ 528.05 ₹ 1044.00
₹ 731.75

Open Price

₹ 750.20

Prev. Close

₹ 746.65

Volume (Shares)

63696.00

Total traded value

₹ 466.09

Upper Circuit

₹ 895.95

Lower Circuit

₹ 597.35

info

KRSNAA DIAGNOSTICS LTD Share Price Update

As of the latest trading session, KRSNAA DIAGNOSTICS LTD share price is currently at ₹ 731.75, which is down by ₹ -14.90 from its previous closing. Today, the stock has fluctuated between ₹ 727.25 and ₹ 755.45. Over the past year, KRSNAA DIAGNOSTICS LTD has achieved a return of 29.52 %. In the last month alone, the return has been -5.55 %. Read More...

KRSNAA DIAGNOSTICS LTD fundamentals


  • Market cap (Cr)

    2,362.80

  • P/E Ratio (TTM)

    30.08

  • Beta

    1.16

  • Book Value / share

    262.88

  • Return on equity

    7.52%

  • EPS (TTM)

    24.83

  • Dividend yield

    0.33%

  • Net profit/quarter (Cr)

    21.60

info icon alternate text
  • Market cap (Cr)

    2,363.61

  • P/E Ratio (TTM)

    30.08

  • Beta

    1.09

  • Book Value / share

    262.88

  • Return on equity

    7.52%

  • EPS (TTM)

    24.83

  • Dividend yield

    0.33%

  • Net profit/quarter (Cr)

    21.60

info icon alternate text

KRSNAA DIAGNOSTICS LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 165.16
Operating Expense 146.07
Net Profit 21.60
Net Profit Margin (%) 13.07
Earnings Per Share (EPS) 6.69
EBITDA 57.19
Effective Tax Rate (%) 23.86
Particulars SEP 2024 (Values in Cr)
Revenue 178.72
Operating Expense 154.82
Net Profit 21.97
Net Profit Margin (%) 12.29
Earnings Per Share (EPS) 6.80
EBITDA 57.09
Effective Tax Rate (%) 22.91
Particulars JUN 2024 (Values in Cr)
Revenue 163.16
Operating Expense 146.95
Net Profit 18.18
Net Profit Margin (%) 11.14
Earnings Per Share (EPS) 5.63
EBITDA 50.30
Effective Tax Rate (%) 22.73
Particulars MAR 2024 (Values in Cr)
Revenue 159.33
Operating Expense 141.48
Net Profit 18.42
Net Profit Margin (%) 11.56
Earnings Per Share (EPS) 5.70
EBITDA 47.62
Effective Tax Rate (%) 16.95
Particulars DEC 2023 (Values in Cr)
Revenue 151.55
Operating Expense 138.76
Net Profit 13.59
Net Profit Margin (%) 8.96
Earnings Per Share (EPS) 4.28
EBITDA 42.24
Effective Tax Rate (%) 19.44
Particulars MAR 2024 (Values in Cr)
Revenue 590.02
Operating Expense 534.87
Net Profit 58.56
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 18.45
EBITDA 162.97
Effective Tax Rate (%) 18.59
Particulars MAR 2023 (Values in Cr)
Revenue 464.08
Operating Expense 401.30
Net Profit 63.51
Net Profit Margin (%) 13.68
Earnings Per Share (EPS) 20.23
EBITDA 143.65
Effective Tax Rate (%) 22.72
Particulars MAR 2022 (Values in Cr)
Revenue 454.89
Operating Expense 380.22
Net Profit 70.70
Net Profit Margin (%) 15.54
Earnings Per Share (EPS) 23.66
EBITDA 149.48
Effective Tax Rate (%) 21.09
Particulars MAR 2021 (Values in Cr)
Revenue 396.46
Operating Expense 366.02
Net Profit 184.93
Net Profit Margin (%) 46.64
Earnings Per Share (EPS) 284.72
EBITDA 358.83
Effective Tax Rate (%) 37.40
Particulars MAR 2020 (Values in Cr)
Revenue 258.43
Operating Expense 429.71
Net Profit -111.95
Net Profit Margin (%) -43.31
Earnings Per Share (EPS) -216.94
EBITDA -101.26
Effective Tax Rate (%) 29.29
Particulars MAR 2024 (Values in Cr)
Book Value / Share 250.79
ROE % 7.34
ROCE % 9.62
Total Debt to Total Equity 0.12
EBITDA Margin 25.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 235.28
ROE % 8.73
ROCE % 11.26
Total Debt to Total Equity 0.05
EBITDA Margin 29.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 217.98
ROE % 9.99
ROCE % 13.90
Total Debt to Total Equity 0.06
EBITDA Margin 32.14
Particulars MAR 2017 (Values in Cr)
Book Value / Share 20.79
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.86
EBITDA Margin 34.35
Particulars MAR 2016 (Values in Cr)
Book Value / Share 21.24
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.33
EBITDA Margin 30.86
Particulars MAR 2024 (Values in Cr)
Book Value / Share 251.73
ROE % 7.52
ROCE % 9.79
Total Debt to Total Equity 0.12
EBITDA Margin 27.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 235.63
ROE % 8.89
ROCE % 11.47
Total Debt to Total Equity 0.05
EBITDA Margin 30.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 218.72
ROE % 19.71
ROCE % 16.99
Total Debt to Total Equity 0.30
EBITDA Margin 32.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share -16.20
ROE % -204.02
ROCE % 59.91
Total Debt to Total Equity 13.27
EBITDA Margin 90.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share -410.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -39.18
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 53.54
Total Assets 1171.91
Total Liabilities 1171.91
Total Equity 809.80
Share Outstanding 32289763
Price to Book Ratio 2.44
Return on Assets (%) 4.84
Return on Capital (%) 6.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 108.79
Total Assets 909.89
Total Liabilities 909.89
Total Equity 738.73
Share Outstanding 31397613
Price to Book Ratio 1.95
Return on Assets (%) 6.82
Return on Capital (%) 8.22
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 241.88
Total Assets 876.15
Total Liabilities 876.15
Total Equity 684.40
Share Outstanding 31397613
Price to Book Ratio 2.22
Return on Assets (%) 7.80
Return on Capital (%) 9.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 53.02
Total Assets 1171.56
Total Liabilities 1171.56
Total Equity 815.24
Share Outstanding 32289763
Price to Book Ratio 2.44
Return on Assets (%) 4.99
Return on Capital (%) 6.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 108.20
Total Assets 909.38
Total Liabilities 909.38
Total Equity 742.50
Share Outstanding 31397613
Price to Book Ratio 1.95
Return on Assets (%) 6.98
Return on Capital (%) 8.37
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 241.75
Total Assets 877.05
Total Liabilities 877.05
Total Equity 686.75
Share Outstanding 31397613
Price to Book Ratio 2.22
Return on Assets (%) 8.06
Return on Capital (%) 9.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 152.91
Total Assets 609.27
Total Liabilities 609.27
Total Equity 231.86
Share Outstanding 6494964
Price to Book Ratio 0.00
Return on Assets (%) 30.35
Return on Capital (%) 41.38
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 127.28
Total Assets 629.98
Total Liabilities 629.98
Total Equity -196.97
Share Outstanding 5163100
Price to Book Ratio 0.00
Return on Assets (%) -17.77
Return on Capital (%) -621.4
Particulars MAR 2024 (Values in Cr)
Net Income 70.00
Cash from Operations 43.14
Cash from Investing -128.87
Cash from Financing 84.18
Net change in Cash -20.34
Free Cash Flow 237.03
Particulars MAR 2023 (Values in Cr)
Net Income 80.20
Cash from Operations 89.43
Cash from Investing -108.88
Cash from Financing -33.14
Net change in Cash -65.73
Free Cash Flow 230.79
Particulars MAR 2022 (Values in Cr)
Net Income 86.51
Cash from Operations 135.05
Cash from Investing -240.63
Cash from Financing 175.99
Net change in Cash 63.77
Free Cash Flow 267.27
Particulars MAR 2024 (Values in Cr)
Net Income 71.94
Cash from Operations 43.19
Cash from Investing -128.87
Cash from Financing 84.20
Net change in Cash -20.27
Free Cash Flow 237.08
Particulars MAR 2023 (Values in Cr)
Net Income 82.19
Cash from Operations 88.61
Cash from Investing -108.54
Cash from Financing -33.13
Net change in Cash -66.19
Free Cash Flow 229.97
Particulars MAR 2022 (Values in Cr)
Net Income 89.60
Cash from Operations 135.33
Cash from Investing -241.09
Cash from Financing 176.03
Net change in Cash 63.64
Free Cash Flow 267.60
Particulars MAR 2021 (Values in Cr)
Net Income 295.45
Cash from Operations 126.33
Cash from Investing -67.37
Cash from Financing 20.03
Net change in Cash 71.32
Free Cash Flow 197.37
Particulars MAR 2020 (Values in Cr)
Net Income -158.33
Cash from Operations 48.01
Cash from Investing -76.64
Cash from Financing 5.77
Net change in Cash -33.06
Free Cash Flow 124.75
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

KRSNAA DIAGNOSTICS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
731.75 -1.99 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 759.70
  • 26 Days 771.60
  • 10 Days 767.40
  • 50 Days 780.70
  • 12 Days 768.80
  • 100 Days 797.90
  • 20 Days 770.80
  • 200 Days 785.90
758.18 PIVOT

First Support

732.47

First Resistance

772.37

Second Support

718.28

Second Resistance

798.08

Third Support

692.57

Third Resistance

812.27

RSI

43.96

ADX

19.61

MACD

-2.82

Williams % R

-58.48

Commodity Channel Index (CCI)

-54.06

Date

2025-04-29

Week

47536.00

Same Day

51521.00

Month

37135.00

1 Year

1.17

3 Year

0.89

Over 1 Month

-5.55%

down

Over 1 Year

29.52%

down

Over 3 Months

-9.42%

down

Over 3 Years

7.06%

down

Over 6 Months

-16.09%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

KRSNAA DIAGNOSTICS LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
54.94%
Promoter Holdings
27.23%
FII
3.55%
DII
14.26%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Rajendra Khivraj Mutha 8029920.0 (24.87%) Shareholding of Promoter and Promoter Group
Phi Capital Trust - Phi Capital Growth Fund - I 4984967.0 (15.44%) Public Shareholding
Tata Mutual Fund - Tata Small Cap Fund 2496000.0 (7.73%) Public Shareholding
Krsna Diagnostics (mumbai) Private Limited 765685.0 (2.37%) Shareholding of Promoter and Promoter Group
K India Opportunities Fund Limited Pcc - Cell S 706085.0 (2.19%) Public Shareholding
Hdfc Life Insurance Company Limited 664743.0 (2.06%) Public Shareholding
Bandhan Bse Healthcare Index Fund 427025.0 (1.32%) Public Shareholding
Kirankumar Prabhakar Bhise 355145.0 (1.1%) Public Shareholding

News

Left Arrow
Right Arrow

KRSNAA DIAGNOSTICS LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2023 2.75 Final 16 Sep 2023 Equity shares
15 Sep 2022 2.5 Final 16 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2023 2.75 Final 16 Sep 2023 Equity shares
15 Sep 2022 2.5 Final 16 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

KRSNAA DIAGNOSTICS LTD Share Price

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010. The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015. Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021.

The Company is primarily engaged in providing diagnostic services centres all over India. The company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services. The Company owns an extensive network of integrated diagnostics centres across India primarily in non-metro and lower-tier cities and towns, with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country.

The Company started operating 12 centres in Himachal Pradesh in public private partnership during the period 2012. It installed 50 centres in 4 states in 2017 and expanded operations across 13 states in 2018. Further, it expanded the operations to over 1500 centres across India in 2020.

The Company in August 2021, came up with an Initial Public Offer of 12,741,036 Equity Shares by raising funds from public aggregating to Rs.1213.33 Crore, comprising a Fresh Issue of 4,215,516 Equity Shares aggregating to Rs 400 Crore and an Offer for Sale of 8,525,520 Equity Shares aggregating to Rs. 813.33 Crore.

The Company operationalized 26 radiology centers, 50 pathology labs, and 556 collection centers in 2022-23. It expanded geographical presence from 660+ centers in FY 2018 to over 2,800 centers in FY 2023. The Teleradiology hub in Pune achieved prestigious accreditation
from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) during the year 2023.

The Company expanded its geographical presence to more than 3600 centres in FY 2024.

Parent organization Indian Private
NSE symbol KRSNAA
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Krsnaa Diagnostics Ltd?

Answer Field

The share price of Krsnaa Diagnostics Ltd for NSE is ₹ 731.75 and for BSE is ₹ 732.

What is the Market Cap of Krsnaa Diagnostics Ltd?

Answer Field

The market cap of Krsnaa Diagnostics Ltd for NSE is ₹ 23,62.80 Cr. and for BSE is ₹ 23,63.61 Cr. as of now.

What is the 52 Week High and Low of Krsnaa Diagnostics Ltd?

Answer Field

The 52 Week High and Low of Krsnaa Diagnostics Ltd for NSE is ₹ 1044.00 and ₹ 528.05 and for BSE is ₹ 1041.80 and ₹ 527.55.

How to Buy Krsnaa Diagnostics Ltd share?

Answer Field

You can trade in Krsnaa Diagnostics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Krsnaa Diagnostics Ltd?

Answer Field

The 1 year returns on the stock has been 29.52%.

What is the Current Share Price of Krsnaa Diagnostics Ltd?

Answer Field

Krsnaa Diagnostics Ltd share price is for NSE ₹ 731.75 & for BSE ₹ 732 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Krsnaa Diagnostics Ltd Share?

Answer Field

The market cap of Krsnaa Diagnostics Ltd for NSE ₹ 23,62.80 & for BSE ₹ 23,63.61 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Krsnaa Diagnostics Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Krsnaa Diagnostics Ltd share is 30.08.

What is the PB ratio of Krsnaa Diagnostics Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Krsnaa Diagnostics Ltd share is 262.88.

How to Buy Krsnaa Diagnostics Ltd Share?

Answer Field

You can trade in Krsnaa Diagnostics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Krsnaa Diagnostics Ltd Share on Bajaj Broking App?

Answer Field

To buy Krsnaa Diagnostics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Krsnaa Diagnostics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|